Navigation Links
Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference
Date:5/12/2008

uct candidates, and other risks identified in Synvista Therapeutics' filings with the Securities and Exchange Commission. Further information on risks faced by Synvista are detailed under the caption "Risk Factors" in Synvista Therapeutics' Annual Report on Form 10-K for the year ended December 31, 2007. These filings are available on a website maintained by the Securities and Exchange Commission at http://www.sec.gov. The information contained in this press release is accurate as of the date indicated. Actual results, events or performance may differ materially. Synvista Therapeutics undertakes no obligation to publicly release the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Synvista Therapeutics to Present at the BIO InvestorForum 2007
2. Synvista Therapeutics to be Featured on Wallst.net
3. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
4. Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
5. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
6. Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
9. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
10. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
11. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...Newswire/ -- Intarcia Therapeutics, Inc. delivered...74; continuous delivery of exenatide) program for ...al Diabetes Technology Meeting in San Francisco, C...nh/20050301/SFTU126LOGO ) ,, Continuous Subcu...Plasma Glucose, HbA1c and Reduces Weight in a 28-d...
(Date:11/5/2009)...PRNewswire/ -- The endangered black-footed ferrets...is rare carnivore feeds on prairie dogs. The pra... entire population die-offs in towns occur. The U...ted a ferret breeding program and has been releasi...tive habitat. Unfortunately, plague can sweep thr...
(Date:11/5/2009)..., November 5, 2009 at 4:30 p.m. Eastern Time ,,...stCall/ - OncoGenex Pharmaceuticals, Inc. ("OncoGe...rted unaudited financial results for the third qua...reviewed the Company,s highlights for the third qu...sults reflect the operations of OncoGenex Technolo...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- Wound Management Technolo...tered into a Letter of Intent to purchase all heal...es, Inc. (OTC Bulletin Board: VHGI). The deal prov...bt, 4,000,000 shares of WNDM and a royalty agreeme... technology being acquired from VHGI. WNDM close...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
...ancellor Carlos Santiago that research projects on...ams at UW-Madison. He,ll probably laugh at you. , ...cent Madison forum on the future of higher educati... are not competing with UW-Madison. These are inst... , ,Likewise, don,t suggest to Santiago that UW-Mi...
...ng this particular article with great anticipation...t I have followed with eagerness as I grew up in t...ars at Pfizer (way before Pfizer was the juggernau...see the annual company ranking results to see how ...moved up or down in the rankings! It was a source ...
...ity of Wisconsin-Milwaukee has announced the fund...in an internal seed-funding competition. , ,The co...search portfolio and contribute to economic develo...wth Initiative. RGI, launched in November of 2005,... research projects to enhance their position in na...
Other Biology Technology:Why Milwaukee needs its own thriving research base 2Why Milwaukee needs its own thriving research base 3Leading global Big Pharma companies of 2005 2Leading global Big Pharma companies of 2005 3Leading global Big Pharma companies of 2005 4Leading global Big Pharma companies of 2005 5Leading global Big Pharma companies of 2005 6Leading global Big Pharma companies of 2005 7Leading global Big Pharma companies of 2005 8UWM announces winners of RGI awards 2
(Date:11/4/2009)... , RIDGE, N.Y., Oct. 21 What,... to preventing accidental death resulting from pre...Parents with good intentions, however, may be unaw...protecting their teens from the ticking timebomb o...ional leader in premium-quality medical supplies, ...
(Date:11/4/2009)... , NEW YORK, Oct. 27 Global R...company and advanced R&D laboratory, today ann...ode and is prepared to actively commercialize its ...-edge biometric security offerings. ,, During t...millions of dollars to develop and deploy a series...
(Date:11/4/2009)... , SEATTLE, Nov. 4 Glencoe So...scopy Environment (OME) Consortium ( http://openm...ration with the American Society of Cell Biology,s...ibrary." The ASCB has been awarded a $2.5M stimulu...s (NIH) Grand Opportunities program, as part of th...
Breaking Biology News(10 mins):MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 2 Study of MM 111 a Bispecific Antibody to ErbB2 3 50725 1Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 2 Study of MM 111 a Bispecific Antibody to ErbB2 3 50725 2Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 2 Study of MM 111 a Bispecific Antibody to ErbB2 3 50725 3Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 2 Study of MM 111 a Bispecific Antibody to ErbB2 3 50725 4McCaughey Urges Use of First NYS Hospital Infection Report 4681 1Bad medicine 50722 1
...iversity of Georgia scientists suggests that curbi... little ?if anything ?to reduce rates of antibioti...reaten human health. , Dr. Margie Lee, professor ... colleagues have found that chickens raised on ant...stine laboratory conditions have high levels of ba...
...ed wormlike insects that nibble on the plant,s lea...an fly larvae that survive eventually evolve metho... and USDA-Agriculture Research Service scientists ...n fly genes that nullify toxins that wheat produce...researchers report their findings in the Feb. 6 is...
... of action, such as Unreal Tournament, can actuall...rsity of Rochester have shown that people who play...he course of a month improved by about 20 percent ...clutter—a visual acuity test similar to ones used ...playing video game improves your bottom line on a ...
Other Biology News:Study finds antibiotic resistance in poultry even when antibiotics were not used 2Study finds antibiotic resistance in poultry even when antibiotics were not used 3Scientists find genes involved in the battle between Hessian flies and wheat 2Scientists find genes involved in the battle between Hessian flies and wheat 3Action video games sharpen vision 20 percent 2
Psoralen from Sigma-Aldrich
CleanBox DNA Workstation from Bio-Rad
Mouse Anti-Human VRK2 Monoclonal Antibody, Unconjugated, Clone 3B10 from Abnova Corporation
Mouse Anti-Human PPIL2 Monoclonal Antibody, Unconjugated, Clone 2E11 from Abnova Corporation
Biology Products: